Delivery Order SPE2DE24D0013-SPE2D625F7VL4

The Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer headquartered in Sunnyvale, California, on July 21, 2025, with an ultimate completion date of July 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and pertains to COVID-19, influenza, and respiratory syncytial virus diagnostic solutions. The contract represents work performed under Cepheid's existing indefinite delivery vehicle arrangements with the Department of Veterans Affairs, which include significant blanket purchase agreements valued at $32.8 million and $2.5 million respectively, enabling continuous procurement of molecular diagnostic testing systems, reagents, and assays across multiple Veterans Integrated Service Networks through 2030.

Cepheid specializes in providing point-of-care and laboratory-based molecular diagnostic systems to federal healthcare entities, with particular focus on infectious disease detection and clinical testing applications. The company's federal contracting portfolio demonstrates consistent delivery of GeneXpert diagnostic equipment and associated reagent supplies to the VA and Defense Logistics Agency. This specific delivery order aligns with Cepheid's core business of supplying respiratory pathogen testing capabilities to support federal healthcare missions, building upon the company's established competitive position in the federal molecular diagnostics marketplace and its demonstrated capability to serve defense and healthcare agency requirements at scale.